FIELD: medicine, pharmaceutics.
SUBSTANCE: there is offered application of 5-biphenyl-4-yl-5-[4-(4-nitrophenyl)-piperazine-1-yl]pyrimidine-2,4,6-trione for preparation of a drug for treatment or prevention of inflammatory bronchial diseases.
EFFECT: higher clinical effectiveness in asthma, decrease in eosinophilia caused by allergen action.
2 cl, 5 tbl, 3 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS OF PYRIMIDINE-2, 4, 6-TRIONES | 2005 |
|
RU2411043C2 |
COMPOSITIONS BASED ON CYCLODEXTRIN AND A BUDESONIDE DERIVATIVE AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2722414C2 |
AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY | 2013 |
|
RU2662314C2 |
ESTRAMUSTINE COMPOSITIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES | 1995 |
|
RU2179036C2 |
COMPOSITION OF CLOPIDOGREL AND SULPHOALKYLESTER CYCLODEXTRIN (VERSIONS) AND METHODS OF TREATING DISEASES BY SAID COMPOSITION (VERSIONS) | 2008 |
|
RU2470636C2 |
INCLUSION COMPLEX OF DISULFIRAM AND CYCLODEXTRIN | 2015 |
|
RU2592625C1 |
METHOD FOR PRODUCTION OF INCLUSION COMPLEXES OF DISULFIRAM WITH CYCLODEXTRIN | 2015 |
|
RU2580567C1 |
HIV-INHIBITING 2-(4-CYANOPHENYLAMINO)-PYRIMIDINE-OXIDE DERIVATIVES | 2006 |
|
RU2398768C2 |
SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON FIPRONIL AND UVEMON FOR TREATING ARACHKOENTOMOSES | 2014 |
|
RU2585384C2 |
NIMEZULIDE SALT-CYCLODEXTRIN INCLUSION COMPLEXES, METHOD OF PREPARING THEREOF AND PHARMACEUTICAL AGENT HAVING ANTIINFLAMMATORY AND ANALGESIC ACTIVITIES | 1994 |
|
RU2129564C1 |
Authors
Dates
2010-10-27—Published
2005-03-31—Filed